The Digital LightCycler System is a next-generation digital PCR system that helps clinical researchers better understand the nature of a patient’s cancer, genetic disease or infection. The new system has the potential to find and quantify ultra-rare, hard to detect mutations, leading to early diagnosis and treatment strategies. The Digital LightCycler System is designed for laboratories performing highly sensitive and precise DNA and RNA […]
The Digital LightCycler System is a next-generation digital PCR system that helps clinical researchers better understand the nature of a patient’s cancer, genetic disease or infection. The new system has the potential to find and quantify ultra-rare, hard to detect mutations, leading to early diagnosis and treatment strategies. The Digital LightCycler System is designed for laboratories performing highly sensitive and precise DNA and RNA […]
Session will focus on disrupting the status quo by empowering consumers to make more proactive, informed health care decisions SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature Anne Wojcicki, co-founder and CEO of personal genomics company 23andMe, at its inaugural Illumina Genomics […]
The Centre of Excellence (CoE) will be focused on advancing research across heart, bone, cartilage and cancer research through the use of 3D bioprinting. CELLINK, the global leader in developing 3D bioprinters and The Indian Institute of Science (IISc) are partnering to establish a CoE for 3D bioprinting in Bengaluru, India. The CoE, the […]
LANSING, Mich. — Neogen Corporation (“Neogen”) (NASDAQ: NEOG) announced that, at the special meeting of Neogen shareholders held today, Neogen shareholders voted to approve all proposals required in connection with the pending combination of the food safety business of 3M Company (“3M”) (NYSE: MMM) with Neogen, including the issuance of shares of Neogen common stock pursuant […]
LGC’s latest environmental, social and governance (ESG) report is now available, covering the period of 1 April 2021 – 31 March 2022. This is LGC’s second ESG report using the Global Reporting Initiative (GRI) Standards, the most widely used sustainability reporting framework globally. Euan O’Sullivan, LGC’s President and Chief Executive Officer, explained, “Last year, I shared […]
Designed to efficiently induce differentiation in ES and iPS cells, AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include isoforms LN-111 and LN-332. This expanded range of laminin isoforms (LN-111, 332, 511, 411 and 221) now provides even greater flexibility and control when tailoring your substrate to the requirements of specific cultured cells. Proven in many […]
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled […]
New partnership will use the power of high-throughput sequencing to measure and understand marine life in our oceans at a rate that eclipses traditional research methods SAN DIEGO — Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific […]
New partnership delivers clinically proven products and manufacturing processes for advanced therapies. We announced a new strategic partnership today with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services. The partnership creates an end-to-end solution for the development and production of hMSC and exosome therapeutics leveraging RoosterBio’s […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
